Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells / L. L. Deng ... [et al.]. -- ilustr., grafy. obr. -- Bibliogr. odkazy - Res. angl.

In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2012. -- s. 1-120. -- ISSN 0028-2685. -- Vol. 59, no. 1 (2012), s. 18-29

1. nádory pľúc 2. apoptóza 3. gény supresorové 4. TRAIL 5. NF-kapa B 6. prežívanie bunky 7. anexín A5 8. down-regulácia 9. reakcia polymerázová reťazová, s reverznou transkriptázou

I. Deng, L. L.
II. Shao, Y. X.
III. Lv, H. F.
IV. Deng, H. B.
V. Lv, F. Z.
VI. Neoplasma : journal of experimental and clinical oncology. -- Vol. 59, no. 1 (2012), s. 18-29

CYLD gén cylindromatózy - expresia CYLD